What Is the Tesamorelin Peptide?
Tesamorelin is a synthetic, stabilized analog of growth-hormone-releasing hormone (GHRH), a hypothalamic peptide. It is based on the full 44-amino-acid GHRH(1-44) sequence, modified by the addition of a trans-3-hexenoyl group at the N-terminus. This acylation confers resistance to enzymatic degradation - most notably cleavage by dipeptidyl peptidase-4 (DPP-4), which rapidly inactivates native GHRH - thereby extending the peptide’s functional stability relative to the unmodified hormone.
Classified as a GHRH analog, Tesamorelin belongs to the growth-hormone secretagogue family. It is studied because it acts upstream in the growth-hormone axis: rather than introducing exogenous growth hormone, it is investigated for its capacity to stimulate the body’s own somatotroph cells. This upstream mechanism has made Tesamorelin a compound of interest in preclinical research on metabolic regulation, body composition, and the broader GH/IGF-1 axis. Amino Labs supplies Tesamorelin strictly for laboratory research use.
Recommended Products
Mechanisms and Pathways Researchers Explore
Tesamorelin binds the GHRH receptor (GHRHR), a class B G-protein-coupled receptor expressed on somatotroph cells of the anterior pituitary. Receptor activation couples primarily to Gs, raising intracellular cAMP and activating protein kinase A, which in turn drives the synthesis and pulsatile release of endogenous growth hormone (GH).
Because it acts upstream, Tesamorelin is studied as a compound that preserves physiological GH pulsatility and remains subject to normal negative feedback from somatostatin and IGF-1 - a mechanistic distinction from administering recombinant GH directly. Downstream, elevated GH acts on hepatic and peripheral receptors to increase insulin-like growth factor-1 (IGF-1), the principal mediator of many GH effects.
Key areas of preclinical and scientific research investigation include:
- Visceral adipose tissue - the most studied axis, examining GHRH-analog-driven GH signaling and its association with fat depot regulation and lipolytic pathways.
- Lipid metabolism - research into triglycerides, lipolysis, and hepatic lipid handling.
- Cognition - exploratory work on GHRH/GH-axis modulation and neurological endpoints.
Within the secretagogue landscape, GHRH analogs such as Tesamorelin, Sermorelin, and CJC-1295 all act at the GHRH receptor - Sermorelin corresponds to the shorter GHRH(1-29) fragment. By contrast, ghrelin-receptor agonists such as Ipamorelin act at a distinct receptor (GHS-R1a). A recurring research theme is that these two pathways are studied as synergistic branches converging on the somatotroph.
Research Handling, Storage, and Quality Considerations
Tesamorelin is supplied as a lyophilized powder, the standard format for research-grade peptides due to its enhanced stability. The dry lyophilate is generally stored sealed and frozen, protected from light, heat, and moisture until it is prepared for use.
For research applications, the powder is reconstituted with an appropriate sterile or bacteriostatic diluent. Reconstituted peptide solutions are typically kept refrigerated at approximately 2-8°C and are less stable than the dry form, so short in-use windows are conventional. Researchers should avoid repeated freeze-thaw cycles of reconstituted material and minimize agitation or foaming, which can promote peptide aggregation.
Reproducible results depend on compound quality. Amino Labs provides Tesamorelin at 99%+ HPLC purity, lyophilized and third-party tested, with batch documentation available. As a Canadian-owned supplier shipping across Canada via Purolator, we prioritize analytical transparency so researchers can attribute observed effects to the compound rather than to impurities. These are general laboratory conventions; actual handling should follow the specific Certificate of Analysis accompanying each batch.